Works by Toshihiko Iuchi


Results: 20
    1
    2

    Distinct patterns of copy number alterations may predict poor outcome in central nervous system germ cell tumors.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-42842-3
    By:
    • Takami, Hirokazu;
    • Satomi, Kaishi;
    • Fukuoka, Kohei;
    • Nakamura, Taishi;
    • Tanaka, Shota;
    • Mukasa, Akitake;
    • Saito, Nobuhito;
    • Suzuki, Tomonari;
    • Yanagisawa, Takaaki;
    • Sugiyama, Kazuhiko;
    • Kanamori, Masayuki;
    • Kumabe, Toshihiro;
    • Tominaga, Teiji;
    • Tamura, Kaoru;
    • Maehara, Taketoshi;
    • Nonaka, Masahiro;
    • Asai, Akio;
    • Yokogami, Kiyotaka;
    • Takeshima, Hideo;
    • Iuchi, Toshihiko
    Publication type:
    Article
    3

    Human chorionic gonadotropin is expressed virtually in all intracranial germ cell tumors.

    Published in:
    Journal of Neuro-Oncology, 2015, v. 124, n. 1, p. 23, doi. 10.1007/s11060-015-1809-y
    By:
    • Takami, Hirokazu;
    • Fukushima, Shintaro;
    • Fukuoka, Kohei;
    • Suzuki, Tomonari;
    • Yanagisawa, Takaaki;
    • Matsushita, Yuko;
    • Nakamura, Taishi;
    • Arita, Hideyuki;
    • Mukasa, Akitake;
    • Saito, Nobuhito;
    • Kanamori, Masayuki;
    • Kumabe, Toshihiro;
    • Tominaga, Teiji;
    • Kobayashi, Keiichi;
    • Nagane, Motoo;
    • Iuchi, Toshihiko;
    • Tamura, Kaoru;
    • Maehara, Taketoshi;
    • Sugiyama, Kazuhiko;
    • Nakada, Mitsutoshi
    Publication type:
    Article
    4
    5
    6

    Transcriptome and methylome analysis of CNS germ cell tumor finds its cell-of-origin in embryogenesis and reveals shared similarities with testicular counterparts.

    Published in:
    Neuro-Oncology, 2022, v. 24, n. 8, p. 1246, doi. 10.1093/neuonc/noac021
    By:
    • Takami, Hirokazu;
    • Elzawahry, Asmaa;
    • Mamatjan, Yasin;
    • Fukushima, Shintaro;
    • Fukuoka, Kohei;
    • Suzuki, Tomonari;
    • Yanagisawa, Takaaki;
    • Matsushita, Yuko;
    • Nakamura, Taishi;
    • Satomi, Kaishi;
    • Tanaka, Shota;
    • Mukasa, Akitake;
    • Saito, Nobuhito;
    • Kanamori, Masayuki;
    • Kumabe, Toshihiro;
    • Tominaga, Teiji;
    • Kobayashi, Keiichi;
    • Nagane, Motoo;
    • Iuchi, Toshihiko;
    • Tamura, Kaoru
    Publication type:
    Article
    7

    12p gain is predominantly observed in non-germinomatous germ cell tumors and identifies an unfavorable subgroup of central nervous system germ cell tumors.

    Published in:
    Neuro-Oncology, 2022, v. 24, n. 5, p. 834, doi. 10.1093/neuonc/noab246
    By:
    • Satomi, Kaishi;
    • Takami, Hirokazu;
    • Fukushima, Shintaro;
    • Yamashita, Satoshi;
    • Matsushita, Yuko;
    • Nakazato, Yoichi;
    • Suzuki, Tomonari;
    • Tanaka, Shota;
    • Mukasa, Akitake;
    • Saito, Nobuhito;
    • Kanamori, Masayuki;
    • Kumabe, Toshihiro;
    • Tominaga, Teiji;
    • Kobayashi, Keiichi;
    • Nagane, Motoo;
    • Iuchi, Toshihiko;
    • Yoshimoto, Koji;
    • Tamura, Kaoru;
    • Maehara, Taketoshi;
    • Sakai, Keiichi
    Publication type:
    Article
    8

    Integrated clinical, histopathological, and molecular data analysis of 190 central nervous system germ cell tumors from the iGCT Consortium.

    Published in:
    Neuro-Oncology, 2019, v. 21, n. 12, p. 1565, doi. 10.1093/neuonc/noz139
    By:
    • Takami, Hirokazu;
    • Fukuoka, Kohei;
    • Fukushima, Shintaro;
    • Nakamura, Taishi;
    • Mukasa, Akitake;
    • Saito, Nobuhito;
    • Yanagisawa, Takaaki;
    • Nakamura, Hideo;
    • Sugiyama, Kazuhiko;
    • Kanamori, Masayuki;
    • Tominaga, Teiji;
    • Maehara, Taketoshi;
    • Nakada, Mitsutoshi;
    • Kanemura, Yonehiro;
    • Asai, Akio;
    • Takeshima, Hideo;
    • Hirose, Yuichi;
    • Iuchi, Toshihiko;
    • Nagane, Motoo;
    • Yoshimoto, Koji
    Publication type:
    Article
    9
    10
    11
    12
    13

    Determining the extent of tumor resection at surgical planning with <sup>18</sup>F-fluciclovine PET/CT in patients with suspected glioma: multicenter phase III trials.

    Published in:
    2021
    By:
    • Wakabayashi, Toshihiko;
    • Hirose, Yuichi;
    • Miyake, Keisuke;
    • Arakawa, Yoshiki;
    • Kagawa, Naoki;
    • Nariai, Tadashi;
    • Narita, Yoshitaka;
    • Nishikawa, Ryo;
    • Tsuyuguchi, Naohiro;
    • Fukami, Tadateru;
    • Sasaki, Hikaru;
    • Sasayama, Takashi;
    • Kondo, Akihide;
    • Iuchi, Toshihiko;
    • Matsuda, Hiroshi;
    • Kubota, Kazuo;
    • Minamimoto, Ryogo;
    • Terauchi, Takashi;
    • Nakazato, Yoichi;
    • Kubomura, Kan
    Publication type:
    journal article
    14
    15

    A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis.

    Published in:
    Neuro-Oncology Practice, 2016, v. 3, n. 4, p. 272, doi. 10.1093/nop/npv064
    By:
    • Motomasa Furuse;
    • Naosuke Nonoguchi;
    • Toshihiko Kuroiwa;
    • Susumu Miyamoto;
    • Yoshiki Arakawa;
    • Jun Shinoda;
    • Kazuhiro Miwa;
    • Toshihiko Iuchi;
    • Koji Tsuboi;
    • Kiyohiro Houkin;
    • Shunsuke Terasaka;
    • Yusuke Tabei;
    • Hideo Nakamura;
    • Motoo Nagane;
    • Kazuhiko Sugiyama;
    • Mizuhiko Terasaki;
    • Tatsuya Abe;
    • Yoshitaka Narita;
    • Nobuhito Saito;
    • Akitake Mukasa
    Publication type:
    Article
    16

    TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations.

    Published in:
    Acta Neuropathologica Communications, 2020, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40478-020-01078-2
    By:
    • Arita, Hideyuki;
    • Matsushita, Yuko;
    • Machida, Ryunosuke;
    • Yamasaki, Kai;
    • Hata, Nobuhiro;
    • Ohno, Makoto;
    • Yamaguchi, Shigeru;
    • Sasayama, Takashi;
    • Tanaka, Shota;
    • Higuchi, Fumi;
    • Iuchi, Toshihiko;
    • Saito, Kuniaki;
    • Kanamori, Masayuki;
    • Matsuda, Ken-ichiro;
    • Miyake, Yohei;
    • Tamura, Kaoru;
    • Tamai, Sho;
    • Nakamura, Taishi;
    • Uda, Takehiro;
    • Okita, Yoshiko
    Publication type:
    Article
    17
    18
    19
    20

    Diagnostic Performance and Safety of Positron Emission Tomography Using <sup>18</sup>F-Fluciclovine in Patients with Clinically Suspected High- or Low-grade Gliomas: A Multicenter Phase IIb Trial.

    Published in:
    Asia Oceania Journal of Nuclear Medicine & Biology, 2017, v. 5, n. 1, p. 10, doi. 10.22038/aojnmb.2016.7869
    By:
    • Toshihiko Wakabayashi;
    • Toshihiko Iuchi;
    • Naohiro Tsuyuguchi;
    • Ryo Nishikawa;
    • Yoshiki Arakawa;
    • Takashi Sasayama;
    • Keisuke Miyake;
    • Tadashi Nariai;
    • Yoshitaka Narita;
    • Naoya Hashimoto;
    • Osamu Okuda;
    • Hiroshi Matsuda;
    • Kazuo Kubota;
    • Kimiteru Ito;
    • Yoichi Nakazato;
    • Kan Kubomura
    Publication type:
    Article